New Data on the Pharmacology of Heparin and Low Molecular Weight Heparins
- 1 January 1996
- journal article
- research article
- Published by Springer Nature in Drugs
- Vol. 52 (7), 8-15
- https://doi.org/10.2165/00003495-199600527-00004
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Pathogenicity of IgA and/or IgM antibodies to heparin–PF4 complexes in patients with heparin‐induced thrombocytopeniaBritish Journal of Haematology, 1996
- Treatment with LMWHs inhibits factor VIIa generation during in vitro coagulation of whole bloodThrombosis Research, 1996
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- The Haemorrhagic Effect of Low Molecular Weight Heparins, Dermatan Sulphate and HirudinPathophysiology of Haemostasis and Thrombosis, 1995
- Effects of Long-Term Therapy with either Heparin or Low-Molecular-Weight Heparin on Serum Lipid LevelsPathophysiology of Haemostasis and Thrombosis, 1995
- A comparison of the antithrombotic effects of heparin and of low molecular weight heparins with increasing antifactor Xa/antifactor IIa ratio in the rabbitBritish Journal of Haematology, 1993
- Comparative effects of enoxaparin and unfractionated heparin in healthy volunteers on prothrombin consumption in whole blood during coagulation, and release of tissue factor pathway inhibitorThrombosis Research, 1993
- Interactions of Heparins in the Vascular EnvironmentPathophysiology of Haemostasis and Thrombosis, 1993
- Low molecular weight heparin in prevention of perioperative thrombosis.BMJ, 1992
- Oligosaccharide mapping of low-molecular-weight heparins: structure and activity differencesJournal of Medicinal Chemistry, 1990